• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • UDI Now Proposed for All Class III Medical Devices and IVDs

UDI Now Proposed for All Class III Medical Devices and IVDs

Monday, 26 July 2021 / Published in Medical Device, News, NMPA Registration in China

UDI Now Proposed for All Class III Medical Devices and IVDs

On July 19, 2021, the NMPA (National Medical Products Administration) published a regulatory draft to solicit public comments on its proposal to require all class III medical devices and IVDs manufactured after March 1, 2022 to have unique device identifiers (UDI). This proposal follows a pilot plan implemented earlier this year requiring only that high-risk class III medical devices have UDIs.

Highlights

Following the implementation of the UDI for the first batch of products, the NMPA suggests the following:

  • For the second batch of medical devices manufactured after March 1, 2022, these are required to have their own UDI, however, the UDI will not be required for medical devices manufactured before March 1, 2022, subject to the manufacturing date indicated on the label.
  • The UDI of the product’s smallest (innermost) packaging unit should be submitted to the UDI registration system from March 1, 2022, onwards.
  • For the second batch of medical devices manufactured after March 1, 2022, the UDI of the product’s smallest (innermost) packaging unit should be uploaded to the UDI database already before selling into the market.

The public consultation is currently open until August 16, 2021.

By Jacky Li and Colleen Xu. Contact Cisema if you would like to learn more.

Tagged under: In vitro diagnostics, UDI, UDID, Unique Device Identification

What you can read next

Standardizing the Classification of Medical Devices
China RoHS 2.0 „Compliance Management Catalog“
Technical Review Guidance Draft for the NMPA Registration of Citric Acid Disinfectants

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.